Maintenance of cytomegalovirus-specific CD4(pos )T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments

INTRODUCTION: Anti-tumor necrosis factor (TNF)-α biotherapies have considerably changed the treatment of rheumatoid arthritis (RA). However, serious infections are a major concern in patients with rheumatic diseases treated with anti-TNF-α. Little is known about viral, especially latent, infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Davignon, Jean-Luc, Boyer, Jean-Frédéric, Jamard, Bénédicte, Nigon, Delphine, Constantin, Arnaud, Cantagrel, Alain
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945035/
https://www.ncbi.nlm.nih.gov/pubmed/20633267
http://dx.doi.org/10.1186/ar3083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945035/
https://www.ncbi.nlm.nih.gov/pubmed/20633267
http://dx.doi.org/10.1186/ar3083

Ejemplares similares